BridgeBio Pharma Inc. logo

BridgeBio Pharma Inc. (BBIO)

Market Open
19 Dec, 17:24
NASDAQ (NGS) NASDAQ (NGS)
$
75. 32
+1.18
+1.59%
$
13.66B Market Cap
- P/E Ratio
0% Div Yield
776,384 Volume
-3.85 Eps
$ 74.14
Previous Close
Day Range
74.41 77.2
Year Range
26.02 77.2
Want to track BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 62 days
Name Time Cons. EPS Eps
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
19 Feb 2026 (In 2 months)
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
11 Nov 2025
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
30 Oct 2025
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
31 Jul 2025
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
30 Apr 2025
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
20 Feb 2025
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
31 Oct 2024
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
1 Aug 2024
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
2 May 2024
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
21 Feb 2024
-
-
BridgeBio Pharma Inc. logo
BBIO BridgeBio Pharma Inc.
1 Nov 2023
-
-

BBIO Earnings Reports FAQ

What is the earnings per share (EPS) for BBIO?

The current EPS is -3.85.

What is the company's earnings growth rate?

BridgeBio Pharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-19, based on the BBIO's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for BridgeBio Pharma Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for BBIO at this time, as BridgeBio Pharma Inc has no recent EPS data to calculate it.